Effects of long-term postoperative oral contraceptive use for the prevention of endometrioma recurrence on bone mineral density in young women

References

• Giudice LC, Tazuke SI, Swiersz L. Status of current research on endometriosis. J Reprod Med 1998;43:252–62
   PubMed Web of Science ®Google Scholar
• Jenkins S, Olive DL, Haney AF. Endometriosis: pathogenetic implications of the anatomic distribution. Obstet Gynecol 1986;67:335–8
   PubMed Web of Science ®Google Scholar
• Garry R. The effectiveness of laparoscopic excision of endometriosis. Curr Opin Obstet Gynecol 2004;16:299–303
   PubMed Web of Science ®Google Scholar
• Guo SW. Recurrence of endometriosis and its control. Hum Reprod Update 2009;15:441–61
   PubMed Web of Science ®Google Scholar
• Lee DY, Bae DS, Yoon BK, Choi D. Post-operative cyclic oral contraceptive use after gonadotrophin-releasing hormone agonist treatment effectively prevents endometrioma recurrence. Hum Reprod 2010;25:3050–4
   PubMed Web of Science ®Google Scholar
• Vercellini P, Somigliana E, Daguati R, et al. Postoperative oral contraceptive exposure and risk of endometrioma recurrence. Am J Obstet Gynecol 2008;198:504.e1–5
   PubMed Web of Science ®Google Scholar
• Vercellini P, DE Matteis S, Somigliana E, et al. Long-term adjuvant therapy for the prevention of postoperative endometrioma recurrence: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2013;92:8–16
   PubMed Web of Science ®Google Scholar
• Ziglar S, Hunter TS. The effect of hormonal oral contraception on acquisition of peak bone mineral density of adolescents and young women. J Pharm Pract 2012;25:331–40
   PubMedGoogle Scholar
• Nappi C, Bifulco G, Tommaselli GA, et al. Hormonal contraception and bone metabolism: a systematic review. Contraception 2012;86:606–21
   PubMed Web of Science ®Google Scholar
• Walsh JS, Henry YM, Fatayerji D, Eastell R. Lumbar spine peak bone mass and bone turnover in men and women: a longitudinal study. Osteoporos Int 2009;20:355–62
   PubMedGoogle Scholar
• Almstedt Shoepe H, Snow CM. Oral contraceptive use in young women is associated with lower bone mineral density than that of controls. Osteoporos Int 2005;16:1538–44
   PubMed Web of Science ®Google Scholar
• Hartard M, Kleinmond C, Wiseman M, et al. Detrimental effect of oral contraceptives on parameters of bone mass and geometry in a cohort of 248 young women. Bone 2007;40:444–50
   PubMed Web of Science ®Google Scholar
• Berenson AB, Rahman M, Wilkinson G. Racial difference in the correlates of bone mineral content/density and age at peak among reproductive-aged women. Osteoporos Int 2009;20:1439–49
   PubMedGoogle Scholar
• Henry YM, Fatayerji D, Eastell R. Attainment of peak bone mass at the lumbar spine, femoral neck and radius in men and women: relative contributions of bone size and volumetric bone mineral density. Osteoporos Int 2004;15:263–73
   PubMed Web of Science ®Google Scholar
• Shivane VK, Sarathi V, Lila AR, et al. Peak bone mineral density and its determinants in an Asian Indian population. J Clin Densito 2012;15:152–8
   PubMedGoogle Scholar
• Beksinska ME, Kleinschmidt I, Smit JA, Farley TM. Bone mineral density in a cohort of adolescents during use of norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives and after discontinuation of norethisterone enanthate. Contraception 2009;79:345–9
   PubMed Web of Science ®Google Scholar
• Scholes D, Hubbard RA, Ichikawa LE, et al. Oral contraceptive use and bone density change in adolescent and young adult women: a prospective study of age, hormone dose, and discontinuation. J Clin Endocrinol Metab 2011;96:E1380–7
   PubMed Web of Science ®Google Scholar
• Cibula D, Skrenkova J, Hill M, Stepan JJ. Low-dose estrogen combined oral contraceptives may negatively influence physiological bone mineral density acquisition during adolescence. Eur J Endocrinol 2012;166:1003–11
   PubMed Web of Science ®Google Scholar
• Lopez LM, Grimes DA, Schulz KF, Curtis KM. Steroidal contraceptives: effect on bone fractures in women. Cochrane Database Syst Rev 2011;CD006033
   PubMedGoogle Scholar
• Warren MP, Miller KK, Olson WH, et al. Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in women with hypothalamic amenorrhea and osteopenia: an open-label extension of a double-blind, placebo-controlled study. Contraception 2005;72:206–11
   PubMed Web of Science ®Google Scholar
• Nappi C, Di Spiezio Sardo A, Greco E, et al. Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density. Obstet Gynecol 2005;105:53–60
   PubMed Web of Science ®Google Scholar
• Endrikat J, Mih E, Dusterberg B, et al. A 3-year double-blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 microg or 30 microg ethinylestradiol in combination with levonorgestrel on bone mineral density. Contraception 2004;69:179–87
   PubMed Web of Science ®Google Scholar
• Gargano V, Massaro M, Morra I, et al. Effects of two low-dose combined oral contraceptives containing drospirenone on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study. Contraception 2008;78:10–15
   PubMed Web of Science ®Google Scholar
• Scholes D, Ichikawa L, LaCroix AZ, et al. Oral contraceptive use and bone density in adolescent and young adult women. Contraception 2010;81:35–40
   PubMed Web of Science ®Google Scholar
• Compston JE. Sex steroids and bone. Physiol Rev 2001;81:419–47
   PubMed Web of Science ®Google Scholar
• Wei S, Winzenberg T, Laslett LL, et al. Oral contraceptive use and bone. Curr Osteoporos Rep 2011;9:6–11
   PubMedGoogle Scholar